Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway

被引:56
|
作者
Ding, Jieqiong [1 ,2 ]
Tang, Qiong [1 ,2 ]
Luo, Binhua [3 ]
Zhang, Lijun [1 ]
Lin, Li [1 ]
Han, Lu [1 ]
Hao, Miaomiao [3 ]
Li, Mingyue [3 ]
Yu, Liangzhu [1 ,2 ]
Li, Mincai [1 ,2 ]
机构
[1] Hubei Univ Sci & Technol, Sch Basic Med Sci, Xianning 437100, Peoples R China
[2] Hubei Univ Sci & Technol, Hubei Key Lab Cardiovasc Cerebrovasc & Metab Diso, Xianning 437100, Peoples R China
[3] Hubei Univ Sci & Technol, Sch Pharm, Xianning 437100, Peoples R China
基金
中国国家自然科学基金;
关键词
Klotho; Hypertrophy; Fibrosis; Transforming growth factor-beta 1; Angiotensin II; LEFT-VENTRICULAR HYPERTROPHY; GROWTH-FACTOR-BETA; PROGRESSION; EXPRESSION; RECEPTORS; MODEL;
D O I
10.1016/j.ejphar.2019.172549
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Recent studies have revealed critical roles of transforming growth factor-beta 1 (TGF-beta 1) and microRNA-132 (miR-132), a downstream mediator of TGF-beta 1, in the pathogenesis of cardiac remodeling. In this study, we tested whether the antiaging protein klotho modifies angiotensin II (Ang II)-induced cardiac remodeling through regulating TGF-beta 1-miR-132 axis. We found that both klotho and the TGF-beta 1 inhibitor LY364947 significantly inhibited cardiac hypertrophy, fibrosis, and dysfunction in Ang II-infused mice, as evidenced by the ratios of heart weight to body weight (HW/BW), heart weight to tibial length (HW/TL), cardiomyocyte cross-sectional area, fibrotic area, and expression of prohypertrophic genes (ANP, beta-MHC) and fibrotic marker genes (alpha-SMA, collagen I), echocardiographic parameters. Meanwhile, klotho also significantly inhibited Ang II-induced protein expression of TGF-beta 1 and phosphorylated Smad2/3 in the heart tissues and cultured cardiomyocytes and cardiac fibroblasts. In vitro experiments demonstrated that Ang II-induced cardiomyocyte hypertrophy and proliferation and activation of cardiac fibroblasts were markedly inhibited by klotho, LY364947 or the miR-132 inhibitor antimiR-beta 2. Both klotho and the TGF-beta 1 inhibitor LY364947 downregulated the miR-132 expression. Additionally, klotho decreased Ang II-induced protein expressions of cardiac fibroblast growth factor (FGF)23 in vivo and in vitro. The decreased protein levels of klotho in serum and renal tissues of Ang II-infused mice were elevated by klotho. Klotho downregulated the protein levels of TGF-beta 1 in renal tissues of Ang II-infused mice. In conclusion, our results suggest that klotho prevents Ang II-induced cardiac remodeling and dysfunction through modifying the TGF-beta 1-miR-132 axis, providing an experimental basis for clinical treatment on cardiac remodeling.
引用
收藏
页数:12
相关论文
共 50 条
  • [11] Heme oxygenase-1 inhibits angiotensin II-induced cardiac hypertrophy
    Hu, CM
    Chen, YH
    Chau, LY
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 163 - 163
  • [12] SALVIANOLIC ACID A ATTENUATES ANGIOTENSIN II-INDUCED CARDIAC FIBROSIS THROUGH REGULATING THE TXNIP SIGNALING PATHWAY
    Ye, Huaqing
    Wang, Kaiyi
    Ma, Jiaxin
    Cui, Sumei
    Guo, Jialin
    Yang, Kehui
    Lyu, Linmao
    SHOCK, 2024, 61 (05): : 748 - 757
  • [13] Pentoxifylline Ameliorates Cardiac Fibrosis, Pathological Hypertrophy, and Cardiac Dysfunction in Angiotensin II-induced Hypertensive Rats
    Zhang, Xiyan
    Meng, Fanqing
    Song, Jie
    Zhang, Li
    Wang, Jiali
    Li, Dongliang
    Li, Liang
    Dong, Ping
    Yang, Bo
    Chen, Yuguo
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2016, 67 (01) : 76 - 85
  • [14] Phosphodiesterase 3A1 Protects the Heart Against Angiotensin II-induced Cardiac Remodeling Through Regulation of Transforming Growth Factor-β Expression
    Iwaya, Shoji
    Oikawa, Masayoshi
    Chen, Yan
    Takeishi, Yasuchika
    INTERNATIONAL HEART JOURNAL, 2014, 55 (02) : 165 - 168
  • [15] Senescence marker protein 30 inhibits angiotensin II-induced cardiac hypertrophy and diastolic dysfunction
    Misaka, Tomofumi
    Suzuki, Satoshi
    Miyata, Makiko
    Kobayashi, Atsushi
    Ishigami, Akihito
    Shishido, Tetsuro
    Saitoh, Shu-ichi
    Kubota, Isao
    Takeishi, Yasuchika
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 439 (01) : 142 - 147
  • [16] Fibroblast growth factor-2 mediates angiotensin II-induced cardiac hypertrophy in hypertensive mice through MAPK activation
    Pellieux, C
    Sauthier, T
    Aubert, JF
    Brunner, HR
    Pedrazzini, T
    JOURNAL OF HYPERTENSION, 2000, 18 : S145 - S145
  • [17] Androgen attenuates cardiac fibroblasts activations through modulations of transforming growth factor-β and angiotensin II signaling
    Chung, Cheng-Chih
    Hsu, Rung-Chieh
    Kao, Yu-Hsun
    Liou, Jing-Ping
    Lu, Yen-Yu
    Chen, Yi-Jen
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 176 (02) : 386 - 393
  • [18] TNF Receptor 1 Signaling Is Critically Involved in Mediating Angiotensin II-Induced Cardiac Fibrosis and Dysfunction
    Haudek, Sandra B.
    Crawford, Jeff
    Reineke, Erin
    Allegre, Alberto A.
    Taffet, George E.
    Trial, JoAnn
    Entman, Mark L.
    CIRCULATION RESEARCH, 2012, 111 (04)
  • [19] Platelet-specific Deletion Of Transforming Growth Factor-β1 Augments Angiotensin Ii-induced Abdominal Aortic Aneurysm In Mice
    Spuzzillo, Anthony R.
    Stone, Bailey
    Benson, Tyler W.
    Brunner, Seth I.
    Wadding-Lee, Caris A.
    Owens, A. Phillip, III
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2024, 44
  • [20] N-acetyl-seryl-aspartyl-lysyl-proline attenuates angiotensin II-induced vascular fibrosis via transforming growth factor-β1 and Smad pathway
    Lin, Chun-Xia
    Yang, Xiao-Ping
    Liao, Tang-Dong
    D'Ambrosio, Martin A.
    Carretero, Oscar A.
    HYPERTENSION, 2007, 50 (04) : E104 - E104